Hamounnavard S, Delirezh N, Afza Ahangaran N. Evaluation of peripheral blood neutrophil survival following treatment with Mesenchymal stem cells in rats. J Mazandaran Univ Med Sci 2014; 24 (112) :34-40
URL:
http://jmums.mazums.ac.ir/article-1-3056-en.html
Abstract: (8615 Views)
Background and purpose: Because of theirmultipotency and ease of purification, amplification and immunomodulatory properties Mesenchymal stem cells (MSC), are anideal stem cell source for cell therapies. This study was done to investigat the effect of Rat MSCs on the survival neutrophils.
Materials and methods: MSCs was isolated from rat (6-8 weeks) femoral and tibial bone marrow and cultured in DMEM. Then maturation MSCs were incubated with neutrophils isolated from peripheral blood of rat at 37 ° C for 1 h. Neutrophil survival was measured at 6 and 24 h incubation with of MSCs by flow cytometric analysis using An/PI. Data were analyzed by SPSSsoftware, followed by Tukeytest at a significance level of (P<0.05).
Results: The 6-hour incubation of neutrophils with MSCs, significantly reduced the percentage of normal cells and increased apoptosis compared to controls and increased cell necrosis was not significant in the treated group than in control. The 24-hour incubation of neutrophils with MSCs, significantly increased the percentage of healthy cells and apoptosis was reduced compared to the control group, and reduced cell necrosis was not significant in the treated groups than in control (p<0.05).
Conclusion: In spite of the clinical importance of MSCs, some biological aspects of them including their self-renewal, proliferation and immune modulatory effects are of great therapeutic potential for cell therapy.